CompletedNCT00235274
Secretin and information processing in schizophrenia
About this title
Read the official source — NCT00235274Medication studyAges 18–55United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- IndianapolisSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateNovember 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Indiana University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00235274
- Official title
Show the full official title
Effects of RG1068 (Secretin) on Information Processing in Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Indianapolis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Indiana University, a university.
Did this study involve medication?
Yes. The study involved medication, including Subcutaneous Secretin.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
